Clinical Trials on Primary Myelofibrosis in United States
Total 25354 results
-
Washington University School of MedicineTakedaTerminatedMyelofibrosesUnited States
-
University of ChicagoRecruitingChronic Myeloid Leukemia | MyelofibrosesUnited States
-
NYU Langone HealthTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | MyelofibrosesUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
John MascarenhasCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruiting
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Center for International Blood and Marrow Transplant...National Cancer Institute (NCI); National Institutes of Health (NIH); National...RecruitingMyelofibrosisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelofibrosisUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
AbbVieTerminatedMyelofibrosis (MF)United States, Korea, Republic of, South Africa
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Anemia | Secondary MyelofibrosisUnited States
-
University of MichiganNational Cancer Institute (NCI); SanofiRecruiting
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationAvailable
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLCTerminated
-
PharmaMarCompletedMyelofibrosisUnited States, Italy
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterCephalonCompleted
-
Ascentage Pharma Group Inc.WithdrawnMyelofibrosisUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterHelsinn Healthcare SACompletedMyeloproliferative DiseasesUnited States
-
Cellenkos, Inc.Recruiting
-
Fred Hutchinson Cancer CenterRecruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Fred Hutchinson Cancer CenterRecruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
National Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedMyeloproliferative DiseasesUnited States
-
University of UtahM.D. Anderson Cancer Center; Baylor College of Medicine; Fred Hutchinson Cancer...Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSecondary MyelofibrosisUnited States
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
Geron CorporationRecruiting
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Celgene; Incyte CorporationActive, not recruitingMyelofibrosisUnited States
-
Geron CorporationCompletedPrimary Myelofibrosis | Secondary Myelofibrosis | Myeloid MalignanciesUnited States
-
Telios Pharma, Inc.RecruitingPrimary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET MyelofibrosisSpain, United States, France, Poland, Italy, Germany
-
Galecto Biotech ABOPIS s.r.lActive, not recruitingMyelofibrosisGermany, Italy, United States, Australia
-
Washington University School of MedicineRigel PharmaceuticalsTerminatedMyelofibrosis | ThrombocytopeniaUnited States
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedMyelofibrosis | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (PPV-MF) | Post-essential Thrombocythemia Myelofibrosis (PET-MF)Germany, United States, Australia, Italy, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
University of UtahRecruiting
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Argentina, Australia, Brazil, Bulgaria, Chile, Hungary, Israel, Italy, Japan, Korea, Republic of, Spain, Sweden, Turkey
-
Northwestern UniversityNational Cancer Institute (NCI); Celgene; The Leukemia and Lymphoma SocietyWithdrawnPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis PhaseUnited States
-
Kartos Therapeutics, Inc.Telios Pharma, Inc.RecruitingPrimary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET MyelofibrosisUnited States, Italy, Serbia, Poland, France, Austria, Bulgaria, Germany, Hungary, Spain
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Myeloproliferative...CompletedMyelofibrosisUnited States, Canada, Italy, Sweden
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumTerminated
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative DisordersUnited States
-
Actuate Therapeutics Inc.Completed